Pharmacotherapeutic follow-up of patients with Chagas disease using benznidazole: drug-related problems and pharmaceutical interventions
Abstract INTRODUCTION Benznidazole (BNZ) is a drug available for the etiological treatment of Chagas disease. However, this drug is toxic and has a limited effectiveness on the chronic phase of this disease, often leading to poor treatment adherence. METHODS: This is a descriptive and explorator...
Main Authors: | João Paulo Ramalho Correia, Alanna Carla da Costa, Eduardo Arrais Rocha, Ana Rosa Pinto Quidute, Darlan da Silva Cândido, Ângela Maria de Souza Ponciano, Marta Maria de França Fonteles, Maria de Fátima Oliveira |
---|---|
Format: | Article |
Language: | English |
Published: |
Sociedade Brasileira de Medicina Tropical (SBMT)
|
Series: | Revista da Sociedade Brasileira de Medicina Tropical |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822017002300334&lng=en&tlng=en |
Similar Items
-
Clinical and serological evolution in chronic Chagas disease patients in a 4-year pharmacotherapy follow-up: a preliminary study
by: Monica Coelho Andrade, et al.
Published: (2013-12-01) -
Characterization of adverse reactions to benznidazole in patients with Chagas disease in the Federal District, Brazil
by: Maria Katarine Costa Lucas Gontijo, et al.
Published: (2020-01-01) -
Tolerance and Adherence of Patients with Chronic Chagas Disease Treated with Benznidazole
by: Cristina Vázquez, et al.
Published: (2023-01-01) -
Implementation of aid as pharmaceutical innovation towards national and foreign pharmaceutical practice
by: L. M. Unhurian, et al.
Published: (2017-02-01) -
Implementation of aid as pharmaceutical innovation towards national and foreign pharmaceutical practice
by: L. M. Unhurian, et al.
Published: (2017-02-01)